Aprea Therapeutics, Inc.: capex
| Value | {"amount": 12165, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-03-31 |
| Status | current |
| Entity | Aprea Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:02:22.995812+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4cabe8ad-b576-4d03-9241-6c8791a3b0dc
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-20-006741Retrieved: 2026-08-19T18:02:22.995812+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001781983/capex/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4cabe8ad-b576-4d03-9241-6c8791a3b0dc
History
- no predecessors — first report